Lobbying client · LD-2 disclosures
Virpax Pharmaceuticals
Pennsylvania
29 filings from 1 registrant · 2019–2026 · latest filed Jul 20, 2026
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
29 filings
Budget/Appropriations
BUD
2 filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- H.R. 925 116th CongressThe Heroes Act2 filingsthrough 2020
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Who did the lobbying
Every lobbyist named on this client's filings.
- Zachary Williams Forbes-Tate30 filingsthrough 2026
- Wesley Ryan Welch Forbes-TateCovered position: Chief of Staff, Senator Kelly Ayotte, April 14 - Jan. 1730 filingsthrough 2026
- Jeffrey Sadosky Forbes-TateCovered position: Communications Director, Senator Rob Portman Communications Director, Senator Kay Bailey Hutchison Deputy Press Secretary, Senator Mike DeWine19 filingsthrough 2023
- EDWARD C. RENO iii Forbes-Tate14 filingsthrough 2022
The filings
The 20 most recent of 29 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: virpax-pharmaceuticals.